Murae Organisor Limited

EARUM

INE060601023

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:54 31/05/2024 BST			5-day change	1st Jan Change
1.59 ^INR	-1.85%		-7.02%	+38.26%

05-29	Murae Organisor Limited announced that it has received INR 247.499999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited	CI
04-24	Murae Organisor Limited Announces Board Appointments	CI

E Earum Pharmaceuticals Limited Approves the Proposal for Opening of Three Overseas Branch Offices

June 26, 2023 at 08:24 am

E Earum Pharmaceuticals Limited approved the proposal for opening of three overseas branch offices of the Company along with such other compliances or procedures necessary or applicable at countries mentioned below: DUBAI, UAE. NIGERIA, WEST AFRICA REGION and KENYA, EAST AFRICA REGION.

Latest news about Murae Organisor Limited

Murae Organisor Limited announced that it has received INR 247.499999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited	05-28	CI
Murae Organisor Limited Announces Board Appointments	04-24	CI
Murae Organisor Limited Appoints Sangita Rajpurohit as Company Secretary and Compliance Officer	04-04	CI
Earum Pharmaceuticals Limited Approves Board Resignations	03-15	CI
Earum Pharmaceuticals' CFO Resigns	02-12	MT
Earum Pharmaceuticals Limited Announces Resignation of Sunil Kumar Patel as Chief Financial Officer	02-10	CI
Earum Pharmaceuticals Limited Approves Appointment of Vaghasiya Brijeshkumar Mathurbhai as Chief Financial Officer	02-09	CI
Earum Pharmaceuticals Limited Announces Change in Corporate Office Address	02-09	CI
Earum Pharmaceuticals Limited Announces Resignation of Sanjaykumar Nai as Non-Executive Director	01-19	CI
Earum Pharmaceuticals Limited Announces Resignation of Vijaykumar Patel as Managing Director	01-19	CI
Murae Organisor Names Managing Director	01-05	MT
Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	12-09	CI
Earum Pharmaceuticals Limited Approves Board Changes	23/08/23	CI
Earum Pharmaceuticals Names CFO	15/08/23	MT
Earum Pharmaceuticals Limited Appoints Sunilkumar Patel as Chief Financial Officer	14/08/23	CI
Earum Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Earum Pharmaceuticals CFO Departs	10/08/23	MT
Earum Pharmaceuticals Limited Announces Executive Changes	09/08/23	CI
Earum Pharmaceuticals Limited Announces Change of Registered Office	09/08/23	CI
Payal Patel Resigns as Chief Financial Officer of Earum Pharmaceuticals Limited	09/08/23	CI
Earum Pharmaceuticals Limited Announces Resignation of Directors	08/08/23	CI
Earum Pharmaceuticals Limited Announces Resignation of Madhuri Mistry from the Position of the Company Secretary	02/08/23	CI
Earum Pharmaceuticals Limited's Board intends to launch an Equity Buyback on July 14, 2023	27/06/23	CI
Earum Pharmaceuticals Plans to Open Three Overseas Branches	26/06/23	MT
E Earum Pharmaceuticals Limited Approves the Proposal for Opening of Three Overseas Branch Offices	26/06/23	CI

Chart Murae Organisor Limited

Duration

Period

More charts

Company Profile

Murae Organisor Limited, formerly Earum Pharmaceuticals Limited, is an India-based pharmaceutical company. The Company is primarily engaged in marketing, trading and distribution of a range of pharmaceutical formulation products, such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by it under its own brand name. It also deals in the trading of active pharmaceutical ingredients (APIâs). Its products include HYGNEX+, HYGNEX+ Spray, EROLON and HYGNEX. It carries its business operations in Indian States, such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan and others.

Sector

Pharmaceuticals

Calendar

28/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MURAE ORGANISOR LIMITED	+38.26%	4.71M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B